Effect of some calcium antagonists on muscarinic receptor-mediated cyclic GMP formation

J Neurochem. 1983 Mar;40(3):705-10. doi: 10.1111/j.1471-4159.1983.tb08036.x.

Abstract

Several calcium antagonists were screened for their effect on muscarinic acetylcholine receptor-mediated cyclic GMP formation in murine neuroblastoma cells (clone N1E-115). Mn2+, Ni2+, and verapamil rapidly antagonized the response noncompetitively, with the following order of potency: verapamil greater than Mn2+ greater than Ni2+. The effects of Mn2+ and Ni2+, but not those of verapamil, were largely reversed by increasing extracellular calcium concentration. Additional effects of these agents included displacement of [3H]quinuclidinyl benzilate binding by verapamil and elevation of cyclic GMP levels by Mn2+ and Ni2+ in the absence of agonists. These results are in support of the hypothesis that receptor-mediated cyclic GMP formation by these cells is dependent upon entry of calcium into the cell and demonstrate the complexity of the effects of calcium antagonists.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / antagonists & inhibitors*
  • Carbachol / pharmacology
  • Cell Line
  • Cyclic GMP / metabolism*
  • Manganese / pharmacology
  • Mice
  • Neuroblastoma / metabolism
  • Nickel / pharmacology
  • Quinuclidinyl Benzilate / metabolism
  • Receptors, Cholinergic / drug effects*
  • Receptors, Muscarinic / drug effects*
  • Verapamil / pharmacology

Substances

  • Receptors, Cholinergic
  • Receptors, Muscarinic
  • Manganese
  • Quinuclidinyl Benzilate
  • Nickel
  • Carbachol
  • Verapamil
  • Cyclic GMP
  • Calcium